IRIS UniCatt

Fargnoli, Maria Concetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.436
AS - Asia 3.025
EU - Europa 1.673
SA - Sud America 591
AF - Africa 102
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.836
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.320
SG - Singapore 1.538
CN - Cina 557
BR - Brasile 497
IT - Italia 317
SE - Svezia 302
VN - Vietnam 245
DE - Germania 232
FR - Francia 195
IN - India 135
IE - Irlanda 122
GB - Regno Unito 118
HK - Hong Kong 114
JP - Giappone 104
FI - Finlandia 86
ID - Indonesia 85
RU - Federazione Russa 69
BD - Bangladesh 63
CA - Canada 52
AR - Argentina 36
MX - Messico 36
AT - Austria 32
KR - Corea 30
BE - Belgio 27
PL - Polonia 27
CI - Costa d'Avorio 26
ZA - Sudafrica 26
ES - Italia 25
IQ - Iraq 24
NL - Olanda 24
TR - Turchia 22
CZ - Repubblica Ceca 21
EC - Ecuador 15
SA - Arabia Saudita 15
CH - Svizzera 14
PK - Pakistan 14
CO - Colombia 12
UA - Ucraina 12
KE - Kenya 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
EG - Egitto 9
JM - Giamaica 9
UZ - Uzbekistan 9
VE - Venezuela 9
LT - Lituania 8
MA - Marocco 8
MY - Malesia 8
PE - Perù 8
JO - Giordania 7
CL - Cile 6
IL - Israele 5
KZ - Kazakistan 5
TN - Tunisia 5
DZ - Algeria 4
GT - Guatemala 4
PH - Filippine 4
AL - Albania 3
AU - Australia 3
CR - Costa Rica 3
DK - Danimarca 3
GH - Ghana 3
IR - Iran 3
LB - Libano 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PY - Paraguay 3
TW - Taiwan 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BM - Bermuda 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BS - Bahamas 2
EU - Europa 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GG - Guernsey 1
GM - Gambi 1
HN - Honduras 1
Totale 8.821
Salva come PNG Salva come JPEG
Città #
Singapore 849
Chandler 420
San Jose 399
Ashburn 307
Dallas 167
Beijing 154
Dublin 122
New York 122
Hong Kong 110
Ann Arbor 98
Tokyo 98
Lauterbourg 90
Los Angeles 86
Jakarta 80
Hefei 79
Ho Chi Minh City 72
Hanoi 67
Hyderabad 64
Boston 63
Milan 63
Bremen 56
Frankfurt am Main 56
Rome 54
Princeton 52
Helsinki 51
San Mateo 46
São Paulo 46
The Dalles 39
Chicago 38
Munich 38
Moscow 37
Wilmington 34
Santa Clara 30
Seoul 29
London 28
St Louis 28
Abidjan 26
Kent 26
Houston 25
Nuremberg 25
Brussels 24
Brooklyn 22
North Bergen 22
Atlanta 21
Paris 21
Lappeenranta 20
Mexico City 20
Orem 18
Buffalo 17
Washington 17
Woodbridge 17
Vienna 16
Brno 15
Council Bluffs 15
Montreal 15
Poplar 15
Cattolica 14
Toronto 14
Warsaw 14
Amsterdam 13
Da Nang 13
Denver 13
Düsseldorf 13
Rio de Janeiro 13
Seattle 13
Chennai 12
Portsmouth 12
Stockholm 12
Belo Horizonte 11
Falkenstein 11
Jacksonville 11
Johannesburg 11
Nairobi 11
Turku 11
Wroclaw 11
Baghdad 10
Boardman 10
Nanjing 10
New Delhi 10
Phoenix 10
San Francisco 10
Brasília 9
Curitiba 9
Haiphong 9
Jeddah 9
Manchester 9
Mumbai 9
Newark 9
Redwood City 9
Ribeirão Preto 9
Saint Cloud 9
Kingston 8
Las Vegas 8
Mountain View 8
Philadelphia 8
Tashkent 8
Amman 7
Ankara 7
Bexley 7
Guangzhou 7
Totale 5.020
Salva come PNG Salva come JPEG
Nome #
Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study 206
A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosis 167
Sclerosing nevus with pseudomelanomatous features: dermoscopic and confocal aspects 161
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023 160
Real-world evidence of biologic treatments in moderate–severe psoriasis in Italy: Results of the CANOVA (EffeCtiveness of biologic treAtmeNts for plaque psOriasis in Italy: An obserVAtional longitudinal study of real-life clinical practice) study 156
Cutaneous squamous cell carcinoma. Italian guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines 154
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study 145
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023 136
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention 131
Advanced Cutaneous Squamous Cell Carcinoma: Italian Multicentric Retrospective Analysis of Patient Profiles and Therapeutic Approaches 129
Pruritus characteristics in a large Italian cohort of psoriatic patients 127
Management of cutaneous melanoma: Comparison of the leading international guidelines updated to the 8th American Joint Committee on Cancer staging system and workup proposal by the Italian Society of Dermatology 126
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study 125
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation 124
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 118
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies 116
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness 115
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 111
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study 110
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference 109
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study 109
Characterization of melanoma susceptibility genes in high-risk patients from Central Italy 107
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019 107
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 107
The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients 107
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma 106
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 106
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 105
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments 105
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 103
5-aminolaevulinic acid patch photodynamic therapy for the treatment of actinic keratoses: preliminary results from an italian study in the real-life setting 103
Assessing the beneficial impact of a patient support program in secukinumab-treated patients with psoriasis in italy 103
Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation 102
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study 100
Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition 100
Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 99
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022 99
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis 99
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 98
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities 98
Treatment adherence with diclofenac 3% gel among patients with multiple actinic keratoses: an integrated low-intensity intervention program versus standard-of-care 98
Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis 97
Psoriasis and its management in women of childbearing age: Tools to increase awareness in dermatologists and patients 96
Treat-to-Target Approach for the Management of Patients with Moderate-to-Severe Plaque Psoriasis: Consensus Recommendations 95
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2019 94
Molecular alterations in basal cell carcinoma subtypes 93
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone family 93
Self-Assessment Questionnaire on Patient-Physician Concordance on Nevus Self-Count and Models Development to Predict High-Risk Phenotype >50 Nevi 92
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 92
Real-World Apremilast Use for Treatment of Plaque Psoriasis in Italy: Patient Perspective, Characteristics, and Clinical Outcomes from the DARWIN Study 91
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study–IL PSO (Italian Landscape Psoriasis) 91
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022 91
Clinical determinants of complete response to vismodegib in locally advanced basal cell carcinoma: a multicentre experience 91
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the Difference 89
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma 88
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility 88
Mycosis fungoides: creation of a prospective, interdisciplinary and multicenter study in central Italy 86
Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study 86
ΜelanoQ: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum Consortium 86
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort study 86
Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’ 85
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic 83
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas 83
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 82
Telomeres and telomerase in cutaneous squamous cell carcinoma 82
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022 81
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study 80
The role of insomnia in the vulnerability to depressive and anxiety symptoms in atopic dermatitis adult patients 79
Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp 79
Response to: Comment on ‘Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines’ 79
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 78
AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST 77
Corrigendum: “Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma” (European Journal of Cancer (2021) 157 (250–258), (S0959804921005360), (10.1016/j.ejca.2021.08.018)) 77
Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients 76
Update on the Management of Pediatric Psoriasis: An Italian Consensus 76
The Risk of Candidiasis During Treatment with Bimekizumab for the Management of Plaque Psoriasis: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 75
Contribution of common genetic variants to familial aggregation of disease and implications for sequencing studies 74
Italian expert consensus paper on the management of patients with actinic keratoses 74
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement 74
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study 70
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 68
Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas 67
High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium 64
The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe 61
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us? 59
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience 57
Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls 51
A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: The EARLY study 50
Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics 49
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study—IL PSO (Italian Landscape PSOriasis) 47
Predictive Factors for Super Responder Status and Long-Term Effectiveness of Guselkumab in Psoriasis: A Multicenter Retrospective Study 47
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results 46
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis) 40
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients—IL PSO (Italian Landscape Psoriasis) 40
Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study–IL PSO (Italian Landscape Psoriasis) 38
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation—IL PSO (Italian Landscape Psoriasis) 26
Totale 8.986
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.824
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.824
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022445 15 8 8 17 29 8 1 66 32 35 111 115
2022/20231.023 111 134 75 184 77 124 29 86 146 16 31 10
2023/2024751 26 184 52 54 47 104 55 10 15 27 88 89
2024/20251.762 41 28 107 56 151 115 60 77 268 206 363 290
2025/20264.524 604 226 238 497 771 266 714 211 316 291 169 221
2026/2027119 119 0 0 0 0 0 0 0 0 0 0 0
Totale 8.986